Profiling tumour heterogeneity through circulating tumour DNA in patients with pancreatic cancer-Reference-Cited by-同舟云学术

Profiling tumour heterogeneity through circulating tumour DNA in patients with pancreatic cancer

Published:2017-08-14 Issue:50 Volume:8 Page:87221-87233
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Adamo Patricia¹,Cowley Caroline M.¹,Neal Christopher P.²,Mistry Vilas¹,Page Karen¹,Dennison Ashley R.²,Isherwood John²,Hastings Robert³,Luo JinLi³,Moore David A.¹,Pringle J. Howard¹,Martins L. Miguel⁴,Pritchard Catrin¹,Manson Margaret¹,Shaw Jacqui A.¹

Affiliation:

1. Department of Cancer Studies, University of Leicester, Robert Kilpatrick Clinical Sciences Building, Leicester Royal Infirmary, Leicester, UK

2. Department of Hepatobiliary and Pancreatic Surgery, Leicester General Hospital, Leicester, UK

3. Cancer Research UK Leicester Centre, University of Leicester, Leicester, UK

4. MRC Toxicology Unit, Leicester, UK

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Building on the clinical applicability of ctDNA analysis in non-metastatic pancreatic ductal adenocarcinoma;Scientific Reports;2024-07-13

2. Building on the clinical applicability of ctDNA analysis in non-metastatic pancreatic ductal adenocarcinoma;2024-05-02

3. Circulating cell-free DNA-based biomarkers for prognostication and disease monitoring in adrenocortical carcinoma;European Journal of Endocrinology;2024-03

4. Clinical Application of Liquid Biopsy in Pancreatic Cancer: A Narrative Review;International Journal of Molecular Sciences;2024-01-29

5. Efficient diagnosis of cancer using biosensing of circulating tumor DNAs(ctDNA): Recent progress and challenges;Microchemical Journal;2023-10